|
Market Cap (20-May) $4,758,880 (1,313th) |
Close (30-Jun) $1.51 |
Volume (30-Jun) 12,937 |
Shortsold (8-Aug) 2,108 (0.02%) (508th) |
|
52w High $1.09 |
52w Low $0.280 |
P/E - |
EPS -0.42 |
ZLD released this announcement to the ASX on 12 July 2021, 8:29. The announcement is marked as price sensitive, and is 2 page(s) in length and 217.81kb in size.
You can view all announcements from ZLD and see how they appear on a price chart on the announcements page.
At the date of this announcement, ZLD was 0.016% short sold according to ASIC data. It was ranked the 570th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.019% of total shares short sold as of the latest reported data (08 August 2024).
| Other Recent Announcements from ZLD | |
|---|---|
| Amendment to ASX announcement - Zelira's diabetic nerve pai | 8 June 2023, 9:47 |
| Initial Director's Interest Notice | 1 June 2023, 15:29 |
| Final Director's Interest Notice | 1 June 2023, 15:27 |
| US Observational Clinical Pain Trial Receives IRB Approval | 12 July 2021, 8:29 |
| Pershing trading restrictions for cannabis companies lifted | 5 July 2021, 8:22 |
| Cantor Fitzgerald - Investor Presentation | 30 June 2021, 9:45 |
| ZLD to present at Cantor Fitzgerald International Conference | 25 June 2021, 8:20 |
You must be logged in to post a reply.
Zelira Therapeutics 